Mubadala enhances its life sciences portfolio by investing in “Envision” –...

Mubadala enhances its life sciences portfolio by investing in “Envision” –...
Mubadala enhances its life sciences portfolio by investing in “Envision” –...

Global Health Care Opportunities (GHO Capital Partners LLP), the European company specialized in investing in the healthcare sector, has announced the strengthening of its investment in the Invision Pharma Group (Invision), a leader in scientific communication services, using the latest technology.

“GHO” completed this investment deal, in cooperation with a consortium of investors, led by Mubadala Investment Company, and which includes both “Harpervist Partners” and “Northwestern Mechanic”, with the aim of moving the company to a new stage of growth. After a successful partnership with “Invision” and “GHO”, which lasted 4 years.

Since its inception in 2001, Invision has been working to provide support to companies that manufacture biological drugs and medical devices in marketing their new products, through drawing medical strategies, developing and implementing strategic plans for dissemination and promotion. The company leverages its iEnvision® technology platform to support clinical strategies and research marketing programs to assist pharmaceutical companies with their work.

Invision has achieved significant growth over the past 19 years, through a number of significant acquisitions in medical strategy, health economics and marketing, and the use of behavioral sciences to disseminate information. This has strengthened its global presence, as it now has more than 800 employees across 14 offices around the world, including Australia, Japan, Serbia and Hungary.

The “GHO” company benefited from its partnership with “Invision”, which lasted for 4 years, to enhance its growth and provide support for the continued expansion of the business. Invision will continue to deploy its proprietary iEnvision technology in order to expand its services in the areas of platform solutions and strategic communication capabilities, and it is expected that it will be able to achieve more success through the integration of these two components.

The acquisitions are expected to play an important role in providing distinguished and diversified services to clients around the world.

David Thompson, CEO of Invision, said: “We have partnered with GHO, which has spanned for four years, and we are happy that they decided to strengthen this partnership and take it to a new stage. We are committed to expanding our activity across health care services, especially medical affairs, with the aim of enhancing the capabilities of doctors to improve services provided to patients.

Partners at GHO Capital said: “We are delighted to continue our successful partnership with David and his team. We got to know Invision closely, and have great confidence in its ability to provide unique services and technologies. We look forward to supporting this ambitious team, through the next stage of growth, and establishing Envision as the preferred strategic partner in the field of medical services, communications and advisory services.

Brian Heberb, Co-President and Founder at Invision, added that the decision by GHO Capital to acquire a majority stake in Invision confirms its conviction and confidence in our business and our vision. We will deal with a team that has adequate knowledge of the healthcare sector, the nature of our business, and has a good relationship, with the leadership of our company, who can make a positive contribution to our new business plan for the next five years.

“GHO” obtained consultations from “Robes and Gray” and “Alvarez and Marsal”, “Invision” also obtained advice from “Irwin Mitchell” and “EY”, and “Ardian” obtained advice from “Rothseld and Company” And Will. Gotchall & Manges ».

Close cooperation

“For the past four years, we have worked closely with the management of Invision and GHO to support the growth of the company,” said Bruno Ladrer, CEO of Ardian Byout UK.

And adding new services, through acquisition, in order to enhance the service provided to its customers. This first investment of the Buyout team in the United Kingdom has achieved great success, and we are confident that the next stage in the path of Invision will strengthen its position as a reliable and preferred partner in the field of medical services for pharmaceutical companies. ”


Follow the economic statement via Google News

Print
Email

Twitter
LinkedIn
Pin Interest
Whats App

These were the details of the news Mubadala enhances its life sciences portfolio by investing in “Envision” –... for this day. We hope that we have succeeded by giving you the full details and information. To follow all our news, you can subscribe to the alerts system or to one of our different systems to provide you with all that is new.

It is also worth noting that the original news has been published and is available at saudi24news and the editorial team at AlKhaleej Today has confirmed it and it has been modified, and it may have been completely transferred or quoted from it and you can read and follow this news from its main source.

PREV Egypt, Sudan airlines sign MoU to boost ties
NEXT Saudi Aramco part of $50 million funding for US software firm